(Q43989797)

28 November 2017

title

Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer (English)

1 reference

28 November 2017

1 reference

Haeyoung Kim

1

1 reference

28 November 2017

Dae-Yeon Cho

2

1 reference

28 November 2017

Doo Ho Choi

3

1 reference

28 November 2017

Su-Youn Choi

4

1 reference

28 November 2017

Inkyung Shin

5

1 reference

28 November 2017

Won Park

6

1 reference

28 November 2017

Seung Jae Huh

7

1 reference

28 November 2017

Sung-Hee Han

8

1 reference

28 November 2017

Min Hyuk Lee

9

1 reference

28 November 2017

Sei Hyun Ahn

10

1 reference

28 November 2017

Byung Ho Son

11

1 reference

28 November 2017

Sung-Won Kim

12

1 reference

28 November 2017

Korean Breast Cancer Study Group

13

1 reference

28 November 2017

Bruce G Haffty

14

1 reference

28 November 2017

language of work or name

English

0 references

publication date

14 July 2012

1 reference

Breast Cancer Research and Treatment

28 November 2017

published in

1 reference

28 November 2017

volume

134

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

1315-1326

1 reference

BRCA mutations in the management of breast cancer: the state of the art.

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Meta-analysis of BRCA1 and BRCA2 penetrance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

BRCA-associated breast cancer in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

The prevalence of BRCA1 mutations among young women with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Founder mutations in BRCA1 and BRCA2 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Nation-wide Korean breast cancer data from 2008 using the breast cancer registration program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Germline mutations of BRCA1 and BRCA2 in Korean breast and/or ovarian cancer families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Germline mutations of BRCA1 and BRCA2 in Korean sporadic ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Comprehensive mutational analysis of BRCA1/BRCA2 for Korean breast cancer patients: evidence of a founder mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Low contribution of BRCA1/2 genomic rearrangement to high-risk breast cancer in the Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Rapid mutation detection in complex genes by heteroduplex analysis with capillary array electrophoresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Prevalence of BRCA mutations and founder effect in high-risk Hispanic families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Performance of BRCA1/2 mutation prediction models in Asian Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

BRCA1 and BRCA2 germline mutation analysis in the Indonesian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Prevalence ofBRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectableBRCA1 andBRCA2 point mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2159-5

10.1007/S10549-012-2159-5

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

28 November 2017

1002590409

0 references

1 reference